Evogene Cash Flow-to-Debt Ratio
Evogene cash flow-to-debt ratio. Evogene (EVGN) has a Cash Flow-to-Debt Ratio of -0.43x as of September 2025, meaning its operating cash flow of ILA-3.79 Million could theoretically repay 0% of its total liabilities (ILA8.83 Million) in one year. Check Evogene (EVGN) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Evogene (2008–2024)
Cash flow-to-debt ratio of Evogene from 2008 to 2024. Historical debt coverage capacity for Evogene across 16 annual periods. Check EVGN capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Evogene Cash Flow-to-Debt Ratio by Year (2008–2024)
Evogene cash flow-to-debt ratio by year from 2008 to 2024. Year-by-year debt coverage analysis for Evogene. For the full cash flow conversion analysis, see EVGN cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (ILA) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.79x | ILA-19.70 Million | ILA25.03 Million | ▲ +18.2% |
| 2023 | -0.96x | ILA-21.58 Million | ILA22.42 Million | ▲ +13.3% |
| 2022 | -1.11x | ILA-23.68 Million | ILA21.34 Million | ▲ +42.4% |
| 2021 | -1.93x | ILA-24.84 Million | ILA12.88 Million | ▼ -48.5% |
| 2020 | -1.30x | ILA-19.51 Million | ILA15.03 Million | ▲ +16.7% |
| 2019 | -1.56x | ILA-17.36 Million | ILA11.15 Million | ▲ +13.8% |
| 2018 | -1.81x | ILA-15.16 Million | ILA8.39 Million | ▲ +6.7% |
| 2017 | -1.94x | ILA-15.93 Million | ILA8.22 Million | ▼ -44.1% |
| 2016 | -1.34x | ILA-11.69 Million | ILA8.70 Million | ▲ +4.2% |
| 2015 | -1.40x | ILA-12.41 Million | ILA8.84 Million | ▼ -81.5% |
| 2014 | -0.77x | ILA-8.89 Million | ILA11.50 Million | ▼ -84.3% |
| 2013 | -0.42x | ILA-5.27 Million | ILA12.56 Million | ▼ -268.7% |
| 2012 | -0.11x | ILA-1.89 Million | ILA16.60 Million | ▼ -205.6% |
| 2011 | 0.11x | ILA2.13 Million | ILA19.80 Million | ▲ +186.2% |
| 2009 | 0.04x | ILA886.00K | ILA23.54 Million | ▼ -92.7% |
| 2008 | 0.52x | ILA12.61 Million | ILA24.34 Million | — |